Facebook Pixel Code
About Sickkids
About SickKids

Petros Pechlivanoglou, M.Sc., PhD

Research Institute
Scientist
Child Health Evaluative Sciences

University of Toronto
Assistant Professor
Institute of Health Policy, Management and Evaluation


Phone: 416-813-7654 (ext. 309484)
Email: petros.pechlivanoglou@sickkids.ca
Alternate Contact: Sabrina Jancsi
Alternate Phone: 416-813-7654 (ext. 309975)
Alternate Email: sabrina.jancsi@sickkids.ca

For more information, visit:

Brief Biography

Petros Pechlivanoglou, PhD, is a Scientist at The Hospital for Sick Children (SickKids) Research Institute and an Assistant Professor at the University of Toronto, Institute of Health Policy Management and Evaluation. He studied economics in his native country, Greece, econometrics at the University of Groningen, the Netherlands and obtained a PhD in health econometrics from the same university. He completed a post-doctoral fellowship at the University of Toronto, within the Toronto Health Economics and Technology Assessment (THETA) Collaborative where he focused on methodological aspects around the application of decision analysis in health-care policy.

Research Interests

  • Use of decision analysis in health care
  • Development of prediction models for economic evaluation
  • Application of evidence synthesis methods in health economics
  • Use of real-world evidence in economic evaluation

Research Activities

Pechlivanoglou's research activities currently are centred on the use of health decision analysis in economic evaluation; bridging evidence synthesis, administrative data and decision analysis; the application and extension of predictive models in health economics as well as other econometric and statistical applications in health economics and health policy, such as the estimation of empirical cost-effectiveness thresholds. He is currently involved in projects around the economics of pre-term birth prevention, the economic evaluation of oncology and ophthalmic interventions in children and adolescents and the economic impact of obstructive sleep apnea and COPD in adults.

Publications

For a complete list of publications, please visit PubMed.

Furzer J, Gupta S, Nathan PC, Schlechter T, Pole JD, Krueger J, Pechlivanoglou P. Cost-effectiveness of Tisagenlecleucel vs Standard Care in High-risk Relapsed Pediatric Acute Lymphoblastic Leukemia in Canada. JAMA Oncology. 2020 Jan. [Epub ahead of print]. doi: 10.1001/jamaoncol.2019.5909.

Tessier L, Furzer J, Hodgson D, Cotton C, Nathan PC, Gupta S, Pechlivanoglou P. Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin’s Lymphoma. Journal of the National Cancer Institute. 2020 Jan 1; 112(1):63-70. doi: 10.1093/jnci/djz037.

Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. (2018). Microsimulation modeling for health decision sciences using R: A tutorial. Medical Decision Making. Apr 2018; 38(3):400-422. doi: 10.1177/0272989X18754513.

Pechlivanoglou P, Abrahamyan L, MacKeigan L, Consiglio GP, Dolovich L, Li P, Cadarette SM, Rac VE, Shin J, Krahn M. Factors affecting the delivery of community pharmacist-led medication reviews: Evidence from the MedsCheck Annual service in Ontario. BMC Health Serv Res. Nov 2016; 16(1):666.

Pechlivanoglou P, Wieringa JE, de Jager T, Postma MJ. (2015). The effect of financial and educational incentives on rational prescribing. A state-space approach. Health Econ. Apr 2015; 24(4):439-53. doi: 10.1002/hec.3030.

Pechlivanoglou P, Abegaz F, Postma MJ, Wit E. (2015). An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons. Pharm Stat. Jul-Aug 2015; 14(4):322-31. doi: 10.1002/pst.1688.